Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Refractory Clear Cell Renal Cell Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00077974
What this trial is testing

A Pivotal Study Of SU011248 In The Treatment Of Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma.

Who this might be right for
Carcinoma, Renal Cell
Pfizer 106
Testing effectiveness (Phase 2)Ended earlyNCT05721222
What this trial is testing

Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)

Who this might be right for
Renal Cell CarcinomaNasopharyngeal CarcinomaNon Hodgkin Lymphoma
Genmab 42
Testing effectiveness (Phase 2)Study completedNCT00550277
What this trial is testing

LBH589 Treatment for Refractory Clear Cell Renal Carcinoma

Who this might be right for
Renal Cell Carcinoma
SCRI Development Innovations, LLC 20
Early research (Phase 1)Ended earlyNCT04438083
What this trial is testing

A Safety and Efficacy Study Evaluating CTX130 in Subjects With Relapsed or Refractory Renal Cell Carcinoma (COBALT-RCC)

Who this might be right for
Renal Cell Carcinoma
CRISPR Therapeutics AG 19
Large-scale testing (Phase 3)Study completedNCT00005995
What this trial is testing

AE-941 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
AEterna Zentaris
Early research (Phase 1)Looking for participantsNCT07297667
What this trial is testing

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Who this might be right for
Alveolar Soft Part SarcomaRenal Cell CarcinomaTriple Negative Breast Cancer
Canadian Cancer Trials Group 30